Rana Navpreet, Gosain Rohit, Lemini Riccardo, Wang Chong, Gabriel Emmanuel, Mohammed Turab, Siromoni Beas, Mukherjee Sarbajit
Department of Medicine, University at Buffalo School of Medicine, Buffalo, NY 14263, USA.
Division of Hematology & Oncology, Roswell Park Comprehensive Cancer Center, University at Buffalo School of Medicine, Buffalo, NY 14263, USA.
Cancers (Basel). 2020 Jan 9;12(1):157. doi: 10.3390/cancers12010157.
Gastric cancer is one of the leading causes of cancer-related mortality worldwide, accounting for 8.2% of cancer-related deaths. The purpose of this study was to investigate the geographic and sociodemographic disparities in gastric adenocarcinoma patients.
We conducted a retrospective study in gastric adenocarcinoma patients between 2004 and 2013. Data were obtained from the National Cancer Data Base (NCDB). Univariate and multivariable analyses were performed to evaluate overall survival (OS). Socio-demographic factors, including the location of residence [metro area (MA) or rural area (RA)], gender, race, insurance status, and marital status, were analyzed.
A total of 88,246 [RA, N = 12,365; MA, N = 75,881] patients were included. Univariate and multivariable analysis showed that RA had worse OS (univariate HR = 1.08, < 0.01; multivariate HR = 1.04; < 0.01) compared to MA. When comparing different racial backgrounds, Native American and African American populations had poorer OS when compared to the white population; however, Asian patients had a better OS (multivariable HR = 0.68, < 0.01). From a quality of care standpoint, MA patients had fewer median days to surgery (28 vs. 33; < 0.01) with fewer positive margins (6.3% vs. 6.9%; < 0.01) when compared to RA patients. When comparing the extent of lymph node dissection, 19.6% of MA patients underwent an extensive dissection (more than or equal to 15 lymph nodes) in comparison to 18.7% patients in RA ( = 0.03).
This study identifies socio-demographic disparities in gastric adenocarcinoma. Future health policy initiatives should focus on equitable allocation of resources to improve the outcomes.
胃癌是全球癌症相关死亡的主要原因之一,占癌症相关死亡的8.2%。本研究的目的是调查胃腺癌患者的地理和社会人口统计学差异。
我们对2004年至2013年间的胃腺癌患者进行了一项回顾性研究。数据来自国家癌症数据库(NCDB)。进行单变量和多变量分析以评估总生存期(OS)。分析了社会人口统计学因素,包括居住地点[都市地区(MA)或农村地区(RA)]、性别、种族、保险状况和婚姻状况。
共纳入88246例患者[RA组,N = 12365;MA组,N = 75881]。单变量和多变量分析显示,与MA组相比,RA组的总生存期较差(单变量HR = 1.08,<0.01;多变量HR = 1.04;<0.01)。在比较不同种族背景时,与白人相比,美国原住民和非裔美国人的总生存期较差;然而,亚洲患者的总生存期较好(多变量HR = 0.68,<0.01)。从医疗质量的角度来看,与RA组患者相比,MA组患者手术的中位天数更少(28天对33天;<0.01),切缘阳性率更低(6.3%对6.9%;<0.01)。在比较淋巴结清扫范围时,19.6%的MA组患者接受了广泛清扫(15个或更多淋巴结),而RA组为18.7%(P = 0.03)。
本研究确定了胃腺癌患者的社会人口统计学差异。未来的卫生政策举措应侧重于资源的公平分配,以改善治疗结果。